Vol.
31
No.
39
October 28, 2005Oct 28, 2005
Free

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

Senate approves NIH funding bill. NCI awards $25 million to eight institutions for patient navigator programs; $35 million awarded for nanotechnology partnerships.

NIH-funded HapMap consortium publishes first phase of catalog.

NIH begins transition to electronic grant submissions; seeks comment on options for NRSA funding.

Login